Literature DB >> 25266263

Port access cardiac operations can be safely performed with either endoaortic balloon or Chitwood clamp.

Pavan Atluri1, Andrew B Goldstone1, Jeanne Fox1, Wilson Y Szeto1, W Clark Hargrove2.   

Abstract

BACKGROUND: Minimally invasive, right thoracotomy (port access) approaches to intracardiac operations (mitral valve, tricuspid valve, atrial septal defect, intracardiac tumors) are becoming increasingly accepted by surgeons, cardiologists, and patients alike. Standard techniques for cardioplegic arrest of the heart have included endoaortic balloons and Chitwood clamps. Concerns have been raised regarding the potential increased risk of vascular adverse events (embolization, dissection, stroke, lower extremity ischemia) associated with endoaortic balloon occlusion. We undertook this study to evaluate the vascular risk associated with endoaortic balloon use.
METHODS: All patients undergoing minimally invasive, port access, right thoracotomy operations from 1998 to 2012 at our institution were retrospectively analyzed. Patients undergoing aortic occlusion with the Chitwood clamp (n=189) were compared with patients undergoing occlusion with the endoaortic balloon (n=875).
RESULTS: There was no statistical difference in the rate of dissection between patients undergoing aortic occlusion with an endoaortic balloon (1.03%) and those receiving a Chitwood clamp (1.06%). Similarly, there was no difference in the rate of type A dissection between aortic occlusion strategies (endoaortic balloon=0.57%, n=5, vs Chitwood clamp=1.06%, n=2, p=0.28). No difference in the incidence of stroke was identified between the endoaortic balloon and the Chitwood clamp (2.2% vs 2.1%, p=1.0).
CONCLUSIONS: Minimally invasive cardiac operations using a peripheral cannulation strategy can be safely performed with minimal vascular adverse events incorporating either endoaortic balloon or Chitwood clamp aortic occlusion. As experience with the endoaortic balloon is gained, the incidence of vascular adverse events can be reduced to nearly negligible rates.
Copyright © 2014 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25266263     DOI: 10.1016/j.athoracsur.2014.06.051

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

1.  Is minimally invasive thoracoscopic surgery the new benchmark for treating mitral valve disease?

Authors:  Andrew B Goldstone; Y Joseph Woo
Journal:  Ann Cardiothorac Surg       Date:  2016-11

2.  Minimally invasive repair of fenestrated atrial septal aneurysm.

Authors:  Seph Naficy; James E Klemis; Steven S Gubin; William R Funderburg; John M Craig
Journal:  J Vis Surg       Date:  2016-01-27

3.  Minimally Invasive Mitral Valve Surgery Provides Excellent Outcomes Without Increased Cost: A Multi-Institutional Analysis.

Authors:  Emily A Downs; Lily E Johnston; Damien J LaPar; Ravi K Ghanta; Irving L Kron; Alan M Speir; Clifford E Fonner; John A Kern; Gorav Ailawadi
Journal:  Ann Thorac Surg       Date:  2016-03-31       Impact factor: 4.330

4.  Transthoracic clamp versus endoaortic balloon occlusion in minimally invasive mitral valve surgery: a systematic review and meta-analysis.

Authors:  Paul Martin Rival; Theresa H M Moore; Alexandra McAleenan; Hamish Hamilton; Zachary Du Toit; Enoch Akowuah; Gianni D Angelini; Hunaid A Vohra
Journal:  Eur J Cardiothorac Surg       Date:  2019-10-01       Impact factor: 4.191

5.  Commentary: Endoaortic balloon occlusion for minimally invasive mitral valve surgery: An empowering alternative.

Authors:  Jake L Rosen; T Sloane Guy
Journal:  JTCVS Tech       Date:  2021-10-13

6.  Minimally invasive and robotic approaches to mitral valve surgery: Transthoracic aortic crossclamping is optimal.

Authors:  Michael J Bates; W Randolph Chitwood
Journal:  JTCVS Tech       Date:  2021-09-22

7.  Long-term results of endoclamping in patients undergoing minimally invasive mitral valve surgery where external aortic clamping cannot be used - a propensity matched analysis.

Authors:  Ayse Cetinkaya; Emad Ebraheem; Karin Bramlage; Stefan Hein; Peter Bramlage; Yeong-Hoon Choi; Markus Schönburg; Manfred Richter
Journal:  J Cardiothorac Surg       Date:  2020-10-14       Impact factor: 1.637

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.